Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.91
Delayed Data
As of 10:41am ET
 +0.03 / +1.60%
Today’s Change
1.84
Today|||52-Week Range
3.78
-23.60%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.88
Today’s open1.87
Day’s range1.85 - 1.91
Volume12,960
Average volume (3 months)166,452
Market cap$147.6M
Dividend yield--
Data as of 10:41am ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-10.53%
Earnings growth (this year)+21.43%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-44.18%
P/E ratioNM
Price/Sales418.96
Price/Book2.08

Competitors

 Today’s
change
Today’s
% change
CURNeuralstem Inc-0.03-1.97%
PLXProtalix Biotherapeu...+0.04+2.80%
CYTRCytRx Corp+0.03+1.22%
FATEFate Therapeutics In...+0.14+2.44%
Data as of 10:42am ET, 09/04/2015

Financials

Next reporting dateSeptember 11, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$379.0K
Annual profit (last year)-$26.9M
Net profit margin-7,106.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President &
Chief Operating Officer
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts

Partner Offers